Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24965)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2019 (publication date) through Sep 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El Jabbour T, Lagana SM, Lee H. Update on hepatocellular carcinoma: Pathologists’ review. World J Gastroenterol 2019; 25(14): 1653-1665 [PMID: 31011252 DOI: 10.3748/wjg.v25.i14.1653] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v25/i14/1653.htm |
| Number | Citing Articles |
| 1 |
М.Т. Orucov, E.T. Şamdancı, Ə.B. Həsənov. ФИБРОЛАМЕЛЛЯРНАЯ ГЕПАТОЦЕЛЛЮЛЯРНАЯ КАРЦИНОМА. Azerbaijan Medical Journal 2023; (3): 172 doi: 10.34921/amj.2023.3.028
|
| 2 |
Xiaojun Luo, Yang Wang, Xi Zhang, Wenbin Liu, Zhongjie Shi. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5735462
|
| 3 |
Qing-fang Wang, Qing-lin Wang, Ming-bo Cao. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.668787
|
| 4 |
Eric Lachance, Jake Mandziuk, Consolato M. Sergi, Justin Bateman, Gavin Low. Liver Cancer. 2021; : 87 doi: 10.36255/exonpublications.livercancer.2021.ch5
|
| 5 |
Takahiro Kodama, Tetsuo Takehara. Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. Seminars in Liver Disease 2024; 44(02): 147 doi: 10.1055/a-2289-2298
|
| 6 |
Soumya Jogi, Radha Varanai, Sravani S. Bantu, Ashish Manne. Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines. Oncology Reviews 2020; 14(2) doi: 10.4081/oncol.2020.515
|
| 7 |
Pattamon Sutthatarn, Cara E. Morin, Jessica Gartrell, Wayne L. Furman, Max R. Langham, Teresa Santiago, Andrew J. Murphy. Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma. Children 2021; 8(3): 226 doi: 10.3390/children8030226
|
| 8 |
Thais Maloberti, Antonio De Leo, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Mattia Riefolo, Michela Visani, Deborah Malvi, Antonia D’Errico, Giovanni Tallini, Francesco Vasuri, Dario de Biase. Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center. World Journal of Gastroenterology 2022; 28(25): 2854-2866 doi: 10.3748/wjg.v28.i25.2854
|
| 9 |
Ioannis A. Ziogas, Laura A. Hickman, Lea K. Matsuoka, Manhal Izzy, Martin I. Montenovo, Scott A. Rega, Irene D. Feurer, Sophoclis P. Alexopoulos. Comparison of Wait‐List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates. Liver Transplantation 2020; 26(9): 1112 doi: 10.1002/lt.25807
|
| 10 |
Hua Ren, Zhi-cheng Wei, Yan-xia Sun, Chun-yan Qiu, Wen-jue Zhang, Wei Zhang, Tao Liu, Xu Che. ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.714264
|
| 11 |
|
| 12 |
Yu Huang, Wenhao Ge, Yuan Ding, Lufei Zhang, Jiarong Zhou, Yang Kong, Bijun Cui, Bingqiang Gao, Xiaohui Qian, Weilin Wang. The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by regulating cyclin-dependent kinase 1 expression. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02351-7
|
| 13 |
Ioannis Parthymos, Redi Bumci, Anna C. Goussia. Intraoperative Flow Cytometry. 2023; : 259 doi: 10.1007/978-3-031-33517-4_18
|
| 14 |
Liyang Wang, Meilong Wu, Chengzhan Zhu, Rui Li, Shiyun Bao, Shizhong Yang, Jiahong Dong. Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1019009
|
| 15 |
Lu Cao, Xiaoqian Ma, Juan Zhang, Cejun Yang, Pengfei Rong, Wei Wang. PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00743-x
|
| 16 |
Feng Dong, Chunlin Ke, Peirong Wang, Biao Chen, Chuanshu Cai. Circ-AKT3 Inhibits Malignant Progression of Hepatocellular Carcinoma by Negatively Regulating PDK1. Journal of Biomedical Nanotechnology 2024; 20(1): 190 doi: 10.1166/jbn.2024.3751
|
| 17 |
Mukul Vij, Julien Calderaro. Pathologic and molecular features of hepatocellular carcinoma: An update. World Journal of Hepatology 2021; 13(4): 393-410 doi: 10.4254/wjh.v13.i4.393
|
| 18 |
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar, Hwajeong Lee. PSMA Immunohistochemistry in Hepatic Neoplasms. American Journal of Surgical Pathology 2022; 46(12): 1688 doi: 10.1097/PAS.0000000000001971
|
| 19 |
Mihajlo Djokic, Maja Cemazar, Masa Bosnjak, Rok Dezman, David Badovinac, Damijan Miklavcic, Bor Kos, Miha Stabuc, Borut Stabuc, Rado Jansa, Peter Popovic, Lojze M. Smid, Gregor Sersa, Blaz Trotovsek. A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular Carcinoma. Cancers 2020; 12(12): 3778 doi: 10.3390/cancers12123778
|
| 20 |
Marianne Ziol. Histoséminaire de la société française de pathologie Histoséminaire « Pathologie tumorale hépatique ». Cas n°7. Annales de Pathologie 2021; 41(5): 449 doi: 10.1016/j.annpat.2021.02.009
|
| 21 |
Michel Kmeid, Georgi Lukose, Kyle Hodge, Daniel Cho, Kelly‐Ann Kim, Hwajeong Lee. Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study. Histopathology 2021; 79(5): 768 doi: 10.1111/his.14420
|
| 22 |
Qi Liu, Yu-yang Liu, Xue-min Chen, Bing-yan Tao, Kuang Chen, Wei-min Li, Chang-tao Xu, Ying Shi, Hao Li, Hao-run Liu. KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1071722
|
| 23 |
Xun Wang, Fang‐yuan Li, Wei Zhao, Zhi‐kang Gao, Bin Shen, Hao Xu, Yan‐feng Cui. Long non‐coding RNA GAS5 overexpression inhibits M2‐like polarization of tumour‐associated macrophages in SMCC‐7721 cells by promoting PTEN expression. International Journal of Experimental Pathology 2020; 101(6): 215 doi: 10.1111/iep.12374
|
| 24 |
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
|
| 25 |
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang. Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864106
|
| 26 |
Abdel-Naser Abdel-Atty Gadallah, Ehab Ahmed Abdel Atti, Tary Abdel Hamid Salman, Abd elSamie Othman Hassan, Hanan M. Bedair. Predictive Role for Serum Aldo-Keto Reductase Family1 Member B10 for Early Detection of Hepatocellular Carcinoma in Egyptian Patients. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1678 doi: 10.3889/oamjms.2022.7149
|
| 27 |
Aoxiao He, Zhihao Huang, Jiakun Wang, Hongcheng Lu, Rongguiyi Zhang, Linquan Wu, Qian Feng, Mallikarjuna Korivi. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/3968303
|
| 28 |
Fei Gao, Gang Zheng, Zhongjie Shi. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/2959846
|
| 29 |
John S. Lubel, Stuart K. Roberts, Jessica Howell, James Ward, Nichols A. Shackel. Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia. Internal Medicine Journal 2021; 51(2): 181 doi: 10.1111/imj.15184
|
| 30 |
Qiheng Gou, Shengya Fu, Yuxin Xie, Mengni Zhang, Yali Shen. Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.621594
|
| 31 |
Yun Li, Hui Xiong. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09398-3
|
| 32 |
Renzhi Hu, Xiping Liang, Qiying Li, Yao Liu, Zhongjie Shi. Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/4869732
|
| 33 |
Bengi Öztürk. Genomic Variations Between Fibrolamellar and Conventional Hepatocellular Carcinomas. Cureus 2023; doi: 10.7759/cureus.50795
|
| 34 |
Chih‐Chieh Yen, Chia‐Jui Yen, Yan‐Shen Shan, Yih‐Jyh Lin, I‐Ting Liu, Hsuan‐Yi Huang, Matthew M Yeh, Shih‐Huang Chan, Hung‐Wen Tsai. Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Histopathology 2021; 79(4): 556 doi: 10.1111/his.14384
|
| 35 |
Yuan Yuan, Yiwan Li, Guoxia Yang, Li Zhang, Jin Ye, Tian jiao Wang. Effect of Comprehensive Nursing Approach in Perioperative Stage of Patients with Hepatocellular Carcinoma Interventional Therapy. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6862463
|
| 36 |
Xiaolin Chen, Qiaosu Zhao, Haibiao Wang, Kaijie Qiu, Xi Deng, Feng Xu. Period2 is associated with immune cell infiltration and is a potential diagnostic and prognostic marker for hepatocellular carcinoma. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1264553
|
| 37 |
Min Xiao, Di Wang, Guo-Ling Lin, Xin Lin, Li-Yan Tao, Qi-Yong Li. Safely Modified Laparoscopic Liver Resection for Segment VI and/or VII Hepatic Lesions Using the Left Lateral Decubitus Position. International Journal of General Medicine 2022; : 6691 doi: 10.2147/IJGM.S376919
|
| 38 |
Charissa Kim, Natasha Cigarroa, Venkateswar Surabhi, Balaji Ganeshan, Anil K. Pillai. Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma. Journal of Personalized Medicine 2020; 10(3): 136 doi: 10.3390/jpm10030136
|
| 39 |
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
|
| 40 |
Chengwu Tang, Hongbin Yu, Yinyuan Zheng, Wenming Feng, Jiasheng Shen, Dong-Hua Yang. lncRNA TINCR Regulates Proliferation and Invasion of Hepatocellular Carcinoma Cells by Regulating the miR-375/ATG7 Axis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/8132403
|
| 41 |
S. Tan, M. Machrumnizar. Fish and Food-Fatale: Food-borne Trematode Opisthorchis viverrini and Cholangiocarcinoma. Helminthologia 2023; 60(4): 287 doi: 10.2478/helm-2023-0036
|
| 42 |
Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85688-3
|
| 43 |
永昌 孟. Identification of Potential Therapeutic Target Gene for Human Hepatocellular Carcinoma: A GEO and TCGA Database Study. Advances in Clinical Medicine 2023; 13(06): 10574 doi: 10.12677/ACM.2023.1361479
|
| 44 |
Dongwei Zhang, Tanzy Love, Yansheng Hao, Bella Lingjia Liu, Swan Thung, Maria Isabel Fiel, Christa L Whitney-Miller, Xiaoyan Liao. Tumor Size, Not Small Vessel Invasion, Predicts Survival in Patients With Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 158(1): 70 doi: 10.1093/ajcp/aqac001
|
| 45 |
Yohan Kim, Young Seok Kim, Jeong-Ju Yoo, Sang Gyune Kim, Susie Chin, Ahrim Moon. Rare case of hepatocellular carcinoma metastasis to urinary bladder: A case report . World Journal of Clinical Cases 2022; 10(16): 5470-5478 doi: 10.12998/wjcc.v10.i16.5470
|
| 46 |
Joon Hyuk Choi, Jae Y. Ro. Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. Biomedicines 2022; 10(8): 1826 doi: 10.3390/biomedicines10081826
|
| 47 |
Abdelaty Shawky Mohamed, Amal Abd El hafez, Ahmed Eltantawy, Mena Mahfouz. Diagnostic and Prognostic Value of Isolated and Combined MCM3 and Glypican-3 Expression in Hepatocellular Carcinoma: A Novel Immunosubtyping Prognostic Model. Applied Immunohistochemistry & Molecular Morphology 2022; 30(10): 694 doi: 10.1097/PAI.0000000000001080
|
| 48 |
Antonios E. Spiliotis, Sebastian Holländer, Gudrun Wagenpfeil, Robert Eisele, Spyridon Nika, Orestis Mallis Kyriakides, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Gereon Gäbelein. Electrochemotherapy with intravenous, intratumoral, or combined administration of bleomycin in the treatment of colorectal hepatic metastases in a rat model. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-67878-x
|
| 49 |
Stefano Restaino, Giulia Pellecchia, Alice Poli, Martina Arcieri, Claudia Andreetta, Laura Mariuzzi, Maria Orsaria, Anna Biasioli, Monica Della Martina, Sergio Giuseppe Intini, Giovanni Scambia, Lorenza Driul, Giuseppe Vizzielli. A Rare Case of Hepatocellular Carcinoma Recurrence in Ovarian Site after 12 Years Mimicking a Hepatoid Adenocarcinoma: Case Report. Journal of Clinical Medicine 2023; 12(7): 2468 doi: 10.3390/jcm12072468
|
| 50 |
Emine Turkmen Samdanci. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99842
|
| 51 |
Nur Rahadiani, Marini Stephanie, Alif Perkasa, Diah Handjari, Ening Krisnuhoni. p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma. Molecular and Clinical Oncology 2023; 19(1) doi: 10.3892/mco.2023.2650
|
| 52 |
Sébastien Mulé, Ali Serhal, Athena Galletto Pregliasco, Jessica Nguyen, Camila Lopes Vendrami, Edouard Reizine, Guang-Yu Yang, Julien Calderaro, Giuliana Amaddeo, Alain Luciani, Frank H. Miller. MRI features associated with HCC histologic subtypes: a western American and European bicenter study. European Radiology 2022; 33(2): 1342 doi: 10.1007/s00330-022-09085-8
|
| 53 |
Zhilei Zhang, Ye Zhou, Yuming Jia, Chao Wang, Meng Zhang, Zhuo Xu. PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03628-9
|
| 54 |
Jun Feng, Aimaiti Yasen, Tianxing Dai, Runbin Liang, Zhihong Liao, Ping He, Zhihong Lin, Guoying Wang. Immunotherapy as adjuvant therapy for a patient with adenosquamous carcinoma of the intrahepatic bile duct: A case report and literature review. Liver Research 2023; 7(2): 156 doi: 10.1016/j.livres.2023.06.002
|
| 55 |
Muhammad Zamil, Hina Maqbool, Sajid Mushtaq, Usman Hassan, Maryam Hameed, Umer Sheikh. Patterns and Clinicopathological Features of Histologically Proven Metastases in Hepatocellular Carcinoma. Cureus 2024; doi: 10.7759/cureus.69385
|
| 56 |
Nese Karadag Soylu. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint. Journal of Gastrointestinal Cancer 2020; 51(4): 1176 doi: 10.1007/s12029-020-00499-5
|
| 57 |
Soo-Jin Cho. Pediatric Liver Tumors. Surgical Pathology Clinics 2020; 13(4): 601 doi: 10.1016/j.path.2020.09.002
|
| 58 |
L.A. Romano, M.da C. Klosterhoff, A.F.F. de Medeiros, S. Oliveira, V.F. Pedrosa. Occurrence of hepatocellular carcinoma in wild pejerrey Odontesthes bonariensis (Teleostei, Atherinidae). Bulletin of the European Association of Fish Pathologists 2022; 41(6) doi: 10.48045/001c.36981
|
| 59 |
Yoon Jung Hwang, Haeryoung Kim. Histomorphological Subtypes of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Review and Update. AJSP: Reviews and Reports 2022; 27(6): 234 doi: 10.1097/PCR.0000000000000531
|
| 60 |
Hua-guo Feng, Chuan-xin Wu, Guo-chao Zhong, Jian-ping Gong, Chun-mu Miao, Bin Xiong. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism. Journal of Cancer Research and Clinical Oncology 2023; 149(17): 15879 doi: 10.1007/s00432-023-05360-3
|
| 61 |
Akihiro Nakayama, Jun Arai, Yumi Otoyama, Ikuya Sugiura, Yoko Nakajima, Atsushi Kajiwara, Yuki Ichikawa, Shojiro Uozumi, Yuu Shimozuma, Manabu Uchikoshi, Masashi Sakaki, Sakiko Tazawa, Eisuke Shiozawa, Toshiko Yamochi, Masafumi Takimoto, Hitoshi Yoshida. Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review. Internal Medicine 2022; 61(2): 189 doi: 10.2169/internalmedicine.7200-21
|
| 62 |
Yunpeng Kong, Yan Jing, Hongmei Sun, Shisheng Zhou, Bhagyaveni M.A. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/5074571
|
| 63 |
Feng Xia, Qiao Zhang, Zhiyuan Huang, Elijah Ndhlovu, Mingyu Zhang, Xiaoping Chen, Bixiang Zhang, Peng Zhu. Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching Analysis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.863790
|
| 64 |
Rama Rao Malla, Rakshmitha Marni, Anandita Chakraborty. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 321 doi: 10.1016/B978-0-323-98807-0.00004-1
|
| 65 |
Wanjing Zheng, Hongjie Huang, Dejun She, Meilian Xiong, Xiaodan Chen, Xiaojun Lin, Dairong Cao. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M. Abdominal Radiology 2022; 47(3): 957 doi: 10.1007/s00261-021-03380-6
|
| 66 |
Anil Aysal, Betul Gundogdu, Burcin Pehlivanoglu, Sumeyye Ekmekci, M. Hasan Toper, Canan Kelten Talu, Ibrahim H. Erdogdu, Duygu Gurel, Merih Guray Durak, Emine Cagnur Ulukus, Sermin Ozkal, Burcin Tuna, Ozgul Sagol, Sulen Sarioglu, Alena Skálová. Biomarkers in Carcinoma of Unknown Primary. 2022; : 335 doi: 10.1007/978-3-030-84432-5_12
|
| 67 |
Wei Jing, Ruoyu Peng, Xiaogai Li, Shaogang Lv, Yu Duan, Shitao Jiang, Fu Wang. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/7267131
|
| 68 |
超 陈. Research Progress of Deep Learning in Pathological Diagnosis of Liver Cancer. Advances in Clinical Medicine 2023; 13(12): 18864 doi: 10.12677/ACM.2023.13122654
|
| 69 |
Anastasia Lemekhova, Daniel Hornuss, Georgios Polychronidis, Philipp Mayer, Christian Rupp, Thomas Longerich, Karl-Heinz Weiss, Markus Büchler, Arianeb Mehrabi, Katrin Hoffmann. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01855-2
|
| 70 |
Caroline Brandi Schlaepfer Sales, Rosane Borges Dias, Ludmila de Faro Valverde, Larissa M. Bomfim, Lais Almeida Silva, Nanashara C. de Carvalho, Jorge Luiz Andrade Bastos, Tatiana Martins Tilli, Gisele Vieira Rocha, Milena Botelho Pereira Soares, Luiz Antonio Rodrigues de Freitas, Clarissa A. Gurgel Rocha, Daniel P. Bezerra. Hedgehog components are overexpressed in a series of liver cancer cases. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70220-0
|
| 71 |
Meenakshi Gupta, Jamal Akhtar, Maryam Sarwat. MicroRNAs: Regulators of immunological reactions in hepatocellular carcinoma. Seminars in Cell & Developmental Biology 2022; 124: 127 doi: 10.1016/j.semcdb.2021.05.025
|
| 72 |
Anil Aysal, Ozgul Sagol. Biomarkers in Carcinoma of Unknown Primary. 2022; : 201 doi: 10.1007/978-3-030-84432-5_8
|
| 73 |
Ruimin Tian, Yanfei Li, Xiaojie Shen, Ying Li. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0756
|
| 74 |
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter Galle. Systemic treatment of HCC in special populations. Journal of Hepatology 2021; 74(4): 931 doi: 10.1016/j.jhep.2020.11.026
|
| 75 |
Xia Chen, Ling Liao, Yuwei Li, Hengliu Huang, Qing Huang, Shaoli Deng. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7653506
|
| 76 |
Joseph W. Franses, Dan G. Duda. Scirrhous HCC: Another ‘omic thread in the HCC tapestry. Hepatology 2023; doi: 10.1097/HEP.0000000000000609
|
| 77 |
Xue‐Song Zheng, Hai‐Jie Liu, Lian‐Lian Zhang, Hui Li, Chun‐Jing Wang, Ye‐Jiu Xin, Rui Hao. MiR‐559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro. The Kaohsiung Journal of Medical Sciences 2020; 36(10): 793 doi: 10.1002/kjm2.12246
|
| 78 |
PeiPei Chen, LiQun Zhang, JinFeng Sun, QiaoYing Xing, Dan Shi. Pre- and post-operative comprehensive nursing care versus conventional nursing care: An evaluation of quality of life, postoperative pain, adverse effects, and treatment satisfaction of patients who underwent surgeries and interventional therapies for liver cancer. Medicine 2023; 102(34): e34643 doi: 10.1097/MD.0000000000034643
|
| 79 |
Stefania Cannito, Umberto Dianzani, Maurizio Parola, Emanuele Albano, Salvatore Sutti. Inflammatory processes involved in NASH-related hepatocellular carcinoma. Bioscience Reports 2023; 43(1) doi: 10.1042/BSR20221271
|
| 80 |
Chun Li, Xin-You Pan, Mingyun Ma, Jun Zhao, Fengda Zhao, Ya-Ping Lv.
Astragalus
polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages
. Pharmaceutical Biology 2021; 59(1): 1531 doi: 10.1080/13880209.2021.1991384
|
| 81 |
Tiemo Sven Gerber, Dirk Andreas Ridder, Mario Schindeldecker, Arndt Weinmann, Diane Duret, Kai Breuhahn, Peter R. Galle, Peter Schirmacher, Wilfried Roth, Hauke Lang, Beate Katharina Straub. Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors. Cells 2022; 11(16): 2507 doi: 10.3390/cells11162507
|
| 82 |
Yongjia Tang, Haoran Xu, Yaxue Dai, Fang Wang, Wenjing Huang, Peifei Liu, Yueqing Gu. A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis. Journal of Materials Chemistry B 2021; 9(22): 4577 doi: 10.1039/D1TB00408E
|
| 83 |
Chengbin Guo, Yuqin Tang, Zhao Yang, Gen Li, Yongqiang Zhang. Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.958161
|
| 84 |
Paula Piedade GARCIA, Ronniel Morais ALBUQUERQUE, Fernanda Maria Farage OSÓRIO, Cláudia Alves COUTO, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. B-RAF PROTEIN IMMUNOEXPRESSION IN HEPATOCELLULAR CARCINOMA DUE TO HEPATITIS C VIRUS RELATED CIRRHOSIS. Arquivos de Gastroenterologia 2021; 58(4): 419 doi: 10.1590/s0004-2803.202100000-76
|
| 85 |
Zhipeng Sun, Guangyang Chen, Liang Wang, Qing Sang, Guangzhong Xu, Nengwei Zhang. APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6. Aging 2022; 14(19): 7959 doi: 10.18632/aging.204325
|
| 86 |
Ricardo V. Lloyd. Pathology: Historical and Contemporary Aspects. 2023; : 85 doi: 10.1007/978-3-031-39554-3_10
|
| 87 |
Hailan Bao, Qi Muge. Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism. Pharmaceutical Biology 2021; 59(1): 1124 doi: 10.1080/13880209.2021.1961825
|
| 88 |
Abdul Razik, Sundeep Malla, Ankur Goyal, Shivanand Gamanagatti, Devasenathipathy Kandasamy, Chandan Jyoti Das, Raju Sharma, Arun Kumar Gupta. Unusual Primary Neoplasms of the Adult Liver: Review of Imaging Appearances and Differential Diagnosis. Current Problems in Diagnostic Radiology 2022; 51(1): 73 doi: 10.1067/j.cpradiol.2020.10.001
|
| 89 |
Aurélie Beaufrère, Julien Calderaro, Valérie Paradis. Combined hepatocellular-cholangiocarcinoma: An update. Journal of Hepatology 2021; 74(5): 1212 doi: 10.1016/j.jhep.2021.01.035
|
| 90 |
Antonios E. Spiliotis, Sebastian Holländer, Jeannette Rudzitis-Auth, Gudrun Wagenpfeil, Robert Eisele, Spyridon Nika, Orestis Mallis Kyriakides, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Gereon Gäbelein. Evaluation of Electrochemotherapy with Bleomycin in the Treatment of Colorectal Hepatic Metastases in a Rat Model. Cancers 2023; 15(5): 1598 doi: 10.3390/cancers15051598
|
| 91 |
Xiao Zhong, Xingwang Hu, Xue‐Gong Fan. Competing risk model for prognostic comparison between clear cell type and common type hepatocellular carcinoma: A population‐based propensity score matching study. Cancer Medicine 2023; 12(9): 10406 doi: 10.1002/cam4.5773
|
| 92 |
Shiming Yi, Chunlei Zhang, Ming Li, Jiafeng Wang, Zhongjie Shi. Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods. Journal of Oncology 2023; 2023: 1 doi: 10.1155/2023/1624580
|
| 93 |
Natalia Pediconi, Debora Salerno, Leonardo Lupacchini, Annapaola Angrisani, Giovanna Peruzzi, Enrico De Smaele, Massimo Levrero, Laura Belloni. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells. Cell Death & Disease 2019; 10(7) doi: 10.1038/s41419-019-1755-2
|
| 94 |
Bufu Tang, Jinyu Zhu, Jie Li, Kai Fan, Yang Gao, Shimiao Cheng, Chunli Kong, Liyun Zheng, Fazong Wu, Qiaoyou Weng, Chenying Lu, Jiansong Ji. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00663-1
|
| 95 |
Suchira Gallage, María García-Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael Mohr, Frank Tacke, Mathias Heikenwalder. The therapeutic landscape of hepatocellular carcinoma. Med 2021; 2(5): 505 doi: 10.1016/j.medj.2021.03.002
|
| 96 |
Hernan R. Bello, Zaid K. Mahdi, Shu K. Lui, Sadhna B. Nandwana, Peter A. Harri, Amir H. Davarpanah. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology‐Pathology Correlation. Journal of Magnetic Resonance Imaging 2022; 55(3): 681 doi: 10.1002/jmri.27553
|
| 97 |
Yuting Hu, Wei Qiu, Zhijun Kong, Siyuan Wu, Yi Liu, Chunfu Zhu, Xihu Qin, Aaron Bell. LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular Carcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/3445970
|